Skip to main content

Table 3 Episodes of vomiting, nausea, dry mouth, drowsiness, colicky pain and continuous pain, symptom distress score

From: Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer

Symptom

Group

Point in treatment

T0

T1

T2

T3

Vomiting

OCT

5.8 ± 0.6

1.5 ± 0.3*

0.5 ± 0.3*

1.2 ± 0.5*

SB

5.4 ± 0.8

4.1 ± 0.7§

2.3 ± 0.6§

2.0 ± 0.8*

Nausea

OCT

2.5 ± 0.4

1.5 ± 0.1

0.3 ± 0.3*

0.2 ± 0.1*

SB

2.8 ± 0.5

1.3 ± 0.4

1.2 ± 0.4§

1.0 ± 0.3§

Dry mouth

OCT

2.1 ± 0.1

1.8 ± 0.3

1.9 ± 0.2

1.8 ± 0.1

SB

1.9 ± 0.2

2.6 ± 0.4

2.7 ± 0.3

2.5 ± 0.4

Drowsiness

OCT

1.6 ± 0.3

1.7 ± 0.2

1.6 ± 0.2

2.0 ± 0.3

SB

1.7 ± 0.2

1.8 ± 0.1

1.5 ± 0.3

1.7 ± 0.3

Colicky pain

OCT

0.4 ± 0.1

0.3 ± 0.1

0.2 ± 0.2

0.4 ± 0.1

SB

0.5 ± 0.2

0.4 ± 0.1

0.4 ± 0.3

0.3 ± 0.1

Continuous pain

OCT

1.7 ± 0.2

0.9 ± 0.4

0.5 ± 0.3

0.6 ± 0.3

SB

1.9 ± 0.1

1.4 ± 0.3

1.3 ± 0.1§

0.7 ± 0.1§

  1. Data are expressed as mean ± SD.
  2. *P < 0.05 for comparison with T0; § P < 0.05 for comparison between groups.